Related references
Note: Only part of the references are listed.被撤回的出版物: Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer (Retracted article. See vol. 36, pg. 2919, 2017)
B. A. Patrick et al.
ONCOGENE (2011)
Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia
Asher Begleiter et al.
LEUKEMIA RESEARCH (2009)
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease
Karim Iskander et al.
CANCER RESEARCH (2008)
NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33ING1b
Marco Garate et al.
EMBO REPORTS (2008)
Potent upregulation of glutathione and NAD(P)H: Quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: Protection against neurotoxicant-elicited cytotoxicity
Zhenquan Jia et al.
NEUROCHEMICAL RESEARCH (2008)
C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment
Christine Yeamans et al.
BLOOD (2007)
被撤回的出版物: NRH:Quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53 (Retracted article. See vol. 75, pg. 615, 2015)
Xing Gong et al.
CANCER RESEARCH (2007)
The highly expressed and inducible endogenous NAD(P)H : quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger
Hong Zhu et al.
CARDIOVASCULAR TOXICOLOGY (2007)
The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol
Gad Asher et al.
BIOCHEMISTRY (2006)
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73
G Asher et al.
GENES & DEVELOPMENT (2005)
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:: Prognostic relevance and analysis of cooperating mutations
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Nrf2 signaling in coordinated activation of antioxidant gene expression
AK Jaiswal
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children
MT Smith et al.
BLOOD (2002)
Transcriptional regulation of granulocyte and monocyte development
AD Friedman
ONCOGENE (2002)
Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults
MT Smith et al.
BLOOD (2001)
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
T Pabst et al.
NATURE GENETICS (2001)
Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:Quinone oxidoreductase 1
D Siegel et al.
MOLECULAR PHARMACOLOGY (2001)
Analysis of the Xenopus laevis CCAAT-enhancer binding protein α gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1
FT Kockar et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
